Podcast Alpha's banner
Podcast Alpha's profile picture

Podcast Alpha

@PodcastAlphaX15,429 subscribers

Signal. Not noise. Forensic breakdowns of the world’s most influential podcasts. Substack - https://t.co/1GNcZMJIWU DM to remove clips

Videos

PodcastAlphaX's profile picture

$GOOGL has an anti-aging asset nobody is pricing. Friedberg david friedberg walked through a Calico paper that should be on Alphabet holders' radar. Calico is Google's longevity lab. Working with Revel Pharma, it used AlphaFold plus directed evolution to design a novel enzyme that degrades CML, the glycation end-product that stiffens tissue and drives aging. The result is not a slide. Across five recursive design cycles the enzyme degraded **52-97%** of CML on human proteins, and on donated skin from patients over 70 it eliminated about **55%** of CML - reversing the skin's profile toward that of a 31-year-old. It is AI-designed proteins doing something genuinely new in biology, not a benchmark score. Chamath Chamath Palihapitiya frames the first market as cosmetic: a workable anti-aging cream is a multi-trillion-dollar category. This is the AlphaFold thesis paying out in a product line, and the AlphaFold-to-drugs bridge is exactly what Demis Hassabis Demis Hassabis has argued is the real near-term return on Google's AI - not chatbots, but designed molecules. Same company, same stack, a second revenue engine the market files under "research." Implication: this is deep-optionality inside a name you already hold on search and cloud. It does not move the $GOOGL model this year. But it is a reminder that Alphabet's AI edge shows up in drug and materials design, an option the Street assigns roughly zero value. If a Calico or Isomorphic asset reaches a real market, that is upside no analyst is underwriting. Watch for Calico or Isomorphic Labs to move a designed molecule toward a commercial or clinical path.

Podcast Alpha

123,739 Aufrufe • vor 1 Monat

PodcastAlphaX's profile picture

PayPal peaked near $322B. It trades around $30-40B now. David Sacks David Sacks walked the fall: a 25-year-old product still growing about 7% a year, cut to a tenth of its peak value. That is not a broken business. That is a cheap one - and cheap plus a strategic acquirer is how you get an M&A event. Chamath Chamath Palihapitiya expects the ~$60-per-share bid to clear **10-to-15% above** the offer, and hinted at a rival bidder with PayPal roots and trillions to spend. That is the arb: the announced price is a floor, not the exit. Friedberg david friedberg framed it as the second instance of a pattern - AI-native operators buying stale, founder-departed businesses and reviving them. The first instance is the cross-podcast anchor. Ryan Cohen Ryan Cohen laid out a $56B plan to take over eBay ($EBAY), the same playbook: a dormant marketplace, a founder long gone, an operator who thinks software and distribution can restart growth. PayPal is that trade with a payments network attached. Implication for $PYPL holders: this is event-driven arb, not a re-rating on fundamentals. The upside is the bidding dynamic - floor bid plus a hinted second buyer - not a bet that PayPal suddenly grows faster. The risk is a deal break on antitrust or financing, which drops it back to a 7%-grower multiple. Size it as a merger-arb position, not a conviction long. Watch for a competing bid to surface. Chamath's "trillions to spend" hint is the catalyst that would reprice this fast.

Podcast Alpha

127,062 Aufrufe • vor 1 Monat